127 related articles for article (PubMed ID: 23712276)
21. The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer.
Richterstetter M; Wullich B; Amann K; Haeberle L; Engehausen DG; Goebell PJ; Krause FS
BJU Int; 2012 Jul; 110(2 Pt 2):E76-9. PubMed ID: 22313727
[TBL] [Abstract][Full Text] [Related]
22. Early vs delayed radical cystectomy for 'high-risk' carcinoma not invading bladder muscle: delay of cystectomy reduces cancer-specific survival.
Jäger W; Thomas C; Haag S; Hampel C; Salzer A; Thüroff JW; Wiesner C
BJU Int; 2011 Oct; 108(8 Pt 2):E284-8. PubMed ID: 21244611
[TBL] [Abstract][Full Text] [Related]
23. Should follow-up cystoscopy in bacillus Calmette-Guérin-treated patients continue after five tumour-free years?
Holmäng S; Ströck V
Eur Urol; 2012 Mar; 61(3):503-7. PubMed ID: 22119022
[TBL] [Abstract][Full Text] [Related]
24. Shorter recurrence-free survival time, higher risk of multiple recurrences: a retrospective study of non-muscle invasive bladder cancer after transurethral resection.
Deng N; Chen JX; Chen LW; Qiu SP; Li XF; Wang DH
Chin Med J (Engl); 2012 Oct; 125(20):3681-6. PubMed ID: 23075724
[TBL] [Abstract][Full Text] [Related]
25. Analysis of Intravesical Recurrence After Bladder-preserving Therapy for Muscle-invasive Bladder Cancer.
Onozawa M; Miyanaga N; Hinotsu S; Miyazaki J; Oikawa T; Kimura T; Takaoka E; Kawai K; Shimazui T; Sakurai H; Nishiyama H; Akaza H
Jpn J Clin Oncol; 2012 Sep; 42(9):825-30. PubMed ID: 22782963
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
Jancke G; Damm O; Rosell J; Jahnson S
Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
28. The value of a second transurethral resection for T1 bladder cancer.
Schwaibold HE; Sivalingam S; May F; Hartung R
BJU Int; 2006 Jun; 97(6):1199-201. PubMed ID: 16566814
[TBL] [Abstract][Full Text] [Related]
29. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
[TBL] [Abstract][Full Text] [Related]
30. Has the creation of a urology residency programme translated in to more surgical exposure for final year residents?
Shu'aibu SI; Ramyil VM; Dakum NK
Niger J Med; 2013; 22(1):57-60. PubMed ID: 23441522
[TBL] [Abstract][Full Text] [Related]
31. Transurethral bladder tumor resection: intraoperative and postoperative complications in a residency setting.
Nieder AM; Meinbach DS; Kim SS; Soloway MS
J Urol; 2005 Dec; 174(6):2307-9. PubMed ID: 16280830
[TBL] [Abstract][Full Text] [Related]
32. Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases.
Engeler DS; Wyler S; Neyer M; Hobi C; Müller J; Schmid HP
Scand J Urol Nephrol; 2008; 42(6):522-7. PubMed ID: 18609290
[TBL] [Abstract][Full Text] [Related]
33. [INTRAOPERATIVE CONTROL OF THE EFFECTIVENESS OF TRANSURETHRAL RESECTION OF NON-MUSCLE-INVASIVE BLADDER CANCER].
Zubkov AJ; Sitdykov JN; Nuriev LR; Sitdykova MJ
Urologiia; 2015; (2):65-7. PubMed ID: 26237810
[TBL] [Abstract][Full Text] [Related]
34. Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression.
Holmang S; Johansson SL
J Urol; 2002 Apr; 167(4):1634-7. PubMed ID: 11912378
[TBL] [Abstract][Full Text] [Related]
35. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
May M; Helke C; Nitzke T; Vogler H; Hoschke B
Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for intravesical recurrence in patients with high-grade T1 bladder cancer in the second TUR era.
Takaoka E; Matsui Y; Inoue T; Miyazaki J; Nakashima M; Kimura T; Oikawa T; Kawai K; Yoshimura K; Habuchi T; Ogawa O; Nishiyama H
Jpn J Clin Oncol; 2013 Apr; 43(4):404-9. PubMed ID: 23444116
[TBL] [Abstract][Full Text] [Related]
37. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience.
Mariappan P; Zachou A; Grigor KM;
Eur Urol; 2010 May; 57(5):843-9. PubMed ID: 19524354
[TBL] [Abstract][Full Text] [Related]
38. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
[TBL] [Abstract][Full Text] [Related]
39. Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high-grade bladder cancer? A long-term follow-up of a randomized study.
Denzinger S; Wieland WF; Otto W; Filbeck T; Knuechel R; Burger M
BJU Int; 2008 Mar; 101(5):566-9. PubMed ID: 17986289
[TBL] [Abstract][Full Text] [Related]
40. Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?
Beijert IJ; Hentschel AE; Bründl J; Compérat EM; Plass K; Rodríguez O; Subiela Henríquez JD; Hernández V; de la Peña E; Alemany I; Turturica D; Pisano F; Soria F; Čapoun O; Bauerová L; Pešl M; Bruins HM; Runneboom W; Herdegen S; Breyer J; Brisuda A; Calatrava A; Rubio-Briones J; Seles M; Mannweiler S; Bosschieter J; Kusuma VRM; Ashabere D; Huebner N; Cotte J; Contieri R; Mertens LS; Claps F; Masson-Lecomte A; Liedberg F; Cohen D; Lunelli L; Cussenot O; El Sheikh S; Volanis D; Côté JF; Rouprêt M; Haitel A; Shariat SF; Mostafid AH; Nieuwenhuijzen JA; Zigeuner R; Dominguez-Escrig JL; Hacek J; Zlotta AR; Burger M; Evert M; Hulsbergen-van de Kaa CA; van der Heijden AG; Kiemeney LALM; Soukup V; Molinaro L; Gontero P; Llorente C; Algaba F; Palou J; N'Dow J; Ribal MJ; van der Kwast TH; Babjuk M; Sylvester RJ; van Rhijn BWG
Int Urol Nephrol; 2024 Apr; 56(4):1323-1333. PubMed ID: 37980689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
